Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 4/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22843296 | 0.91 | KMT2A (0.53) | KMT2AHSD17B14KDM4ECNR2CES2 | |
| SCHEMBL22843278 | 0.89 | KMT2A (0.51) | KMT2AHSD17B14KDM4ECNR2CES2 | |
| SCHEMBL22843323 | 0.80 | KDM4E (0.41) | KMT2AHSD17B14KDM4ECNR2CES2 | |
| SCHEMBL26194312 | 0.79 | CNR2 (0.62) | KMT2AKDM4ECNR2ALDH1A1LMNA | |
| SCHEMBL6947603 | 0.72 | HSD17B14 (0.74) | KMT2AHSD17B14KDM4ECES2CES1 | |
| SCHEMBL7266631 | 0.72 | KMT2A (0.62) | KMT2AHSD17B14KDM4ECES2CES1 | |
| SCHEMBL28419387 | 0.72 | KMT2A (0.50) | KMT2AHSD17B14KDM4ECES2CES1 | |
| SCHEMBL11712866 | 0.71 | KMT2A (0.61) | KMT2AHSD17B14KDM4ECES2CES1 | |
| SCHEMBL3836387 | 0.71 | KMT2A (0.61) | KMT2AHSD17B14CES2CES1ALDH1A1 | |
| SCHEMBL29373829 | 0.70 | KMT2A (1.00) | KMT2AHSD17B14KDM4ECNR2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11751474-B2 | Compound and organic light emitting display device | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| US-11751474-B2 | Compound and organic light emitting display device | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| US-20200411769-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DISPLAY DEVICE | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2020-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200411769-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DISPLAY DEVICE | L1CAM, C1S, CCNE2 | KMT2A 3702/4885HSD17B14 3812/4885KDM4E 3712/4885 |
| US-11751474-B2 | Compound and organic light emitting display device | L1CAM, C1S, CCNE2 | KMT2A 3702/4885HSD17B14 3812/4885KDM4E 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.